Powered By Google
Laboratories:
- By PI Laboratory:
-
- Bashford, Don, PhD
- Chen, Taosheng, PhD, PMP®
- Evans, William E., PharmD
- Fujii, Naoaki, PhD
- Guy, Kip R., PhD
- Kriwacki, Richard W., PhD
- McKinney-Freeman, Shannon, PhD
- Mittag, Tanja, PhD
- Mullighan, Charles, MBBS(Hons), MSc, MD
- Pillai, Asha B., MD
- Potter, Philip M., PhD
- Rivas, Fatima, PhD
- Snyder, Scott E., PhD
- Webb, Thomas R., PhD
- Zhang, Jinghui, PhD
Supplemental Data:
- By Author
-
- Rabin, K. R.
- Radin, Jana N.
- Radtke, Ina
- Rai, Shesh N.
- Raimondi, Susana, PhD
- Rakestraw, Karen M.
- Reaman, G.
- Relling, Mary V., PharmD
- Ribeiro, Raul, MD
- Rivas, Fatima, PhD
- Rochette, Sheila A., PhD
- Rodriguez-Galindo, Carlos, MD
- Ross, Mary E., MD, PhD
- Roussel, Martine F., PhD
- Ruan, Hong
- Rubnitz, Jeffrey, MD, PhD
- Rutka, Jim
Select last name: ABCD EFGHIJKLMNO PQRSTUVWXY Z See Full List
Supplementary Information
Identification of genes associated with chemotherapy cross-resistance and treatment response in childhood acute lymphoblastic leukemia.
Supplemental Figure 1: Correlation of in vitro sensitivity of primary ALL cells.
Pair-wise correlation of log-transormed LC50 values of prednisolone (PRD), vincristine (VCR), asparaginase (ASP) and daunorubicin (DNR) with corresponding rho by Spearman's Rank correlation (*P<0.0001). Cross-sensitive (green) and cross-resistant (red) patients correspond to the top and bottom quartile by first component of the PCA; illustrated in black are the patients categorized as intermediates.
